[{"Assets_0_Q3_USD":3721422000.0,"CommonStockSharesOutstanding_0_Q3_shares":186790429.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":234952000.0,"NetIncomeLoss_1_Q3_USD":18234000.0,"NetIncomeLoss_3_Q3_USD":-19749000.0,"StockholdersEquity_0_Q3_USD":1555573000.0,"EarningsPerShareBasic_1_Q3_USD":0.1,"EarningsPerShareBasic_3_Q3_USD":-0.11,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":186470141.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":181949838.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON THERAPEUTICS PUBLIC LTD CO","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]